Medications for chronic kidney disease
Pro Research Analysisby 
Searched over 200M research papers
Medication Classes for Chronic Kidney Disease (CKD) Management
Patients with chronic kidney disease often require multiple medications to manage both the disease itself and its complications. Commonly used drug classes include renin-angiotensin-aldosterone system (RAAS) inhibitors, diuretics, adrenal glucocorticoids, immunosuppressants, anticoagulants, antibacterial agents, and, in some regions, traditional medicines. These medications are frequently adjusted based on kidney function to avoid drug accumulation and side effects, as most are excreted through the kidneys either unchanged or as metabolites 110.
New and Investigational Medications for CKD
Recent research highlights the promise of sodium-glucose cotransporter 2 (SGLT2) inhibitors, which slow CKD progression and offer cardiorenal protection. Other novel agents under investigation include non-steroidal mineralocorticoid receptor antagonists (such as finerenone), anti-inflammatory drugs like canakinumab, and pentoxifylline. Autologous cell therapy is also being explored as a future treatment option. These new therapies aim to address the underlying mechanisms of CKD and improve patient outcomes 3459.
Medication Safety and Dose Adjustments in CKD
Many drugs can worsen kidney function or cause nephrotoxicity, so careful selection and dosing are essential. For example, bisphosphonates and hypnotics may accelerate CKD progression, while newer antiviral agents like tenofovir alafenamide (TAF) and tenofovir amibufenamide (TMF) are safer alternatives to older drugs. Some medications, such as remdesivir and molnupiravir, have specific dosing recommendations or safety profiles for CKD patients. Regular review and adjustment of medications are necessary to minimize harm and optimize therapy 210.
Polypharmacy and Inappropriate Prescribing Risks
Elderly CKD patients are especially vulnerable to polypharmacy, often taking a median of nine medications daily. This increases the risk of inappropriate prescriptions, drug interactions, and adverse effects. Antihypertensives, antithrombotics, and antianemics are among the most frequently prescribed drugs. Regular reassessment of medication regimens is crucial, particularly for drugs that are renally excreted or potentially inappropriate for older adults 610.
Medication Adherence Challenges in CKD
Adherence to complex medication regimens is a significant challenge for CKD patients, who may take more than 20 pills per day. Factors influencing adherence include logistical issues, patient beliefs about medications, side effects, cost, and the quality of the patient-provider relationship. Strategies to improve adherence involve patient education, integrating medication-taking into daily routines, and involving patients in treatment decisions 78.
Drug Stewardship and Multidisciplinary Care
Effective medication management in CKD requires a drug stewardship approach, which includes medication reconciliation, selection, dose adjustment, monitoring, and deprescribing when appropriate. Multidisciplinary care teams, including pharmacists, play a key role in optimizing therapy, addressing gaps in care, and supporting patient education and engagement. Digital health tools and shared decision-making further enhance medication safety and effectiveness 910.
Conclusion
Managing chronic kidney disease with medications is complex due to altered drug handling, the risk of drug-induced harm, and the need for individualized therapy. New drug classes and investigational therapies offer hope for better outcomes, but careful attention to medication safety, adherence, and stewardship remains essential for all CKD patients 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic
Investigational new drugs for the treatment of chronic renal failure: an overview of the literature
SGLT2 inhibitors and autologous cell-therapy show promise in slowing the progression of chronic kidney disease, while other therapeutic strategies show potential benefits.
Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease
Elderly patients with advanced chronic kidney disease are at risk of medication-related problems, requiring reassessment of each prescription.
Adherence to medication in patients with chronic kidney disease: a systematic review of qualitative research
Patients with chronic kidney disease can improve medication adherence by mapping their daily activities, addressing beliefs about medications, and involving them in treatment decisions.
Drug adherence in chronic kidney diseases and dialysis.
Poor drug adherence in chronic kidney disease patients is often underestimated, but there are ways to improve it and ensure patients receive the full benefits of their treatments.
DOI
Using guideline-directed medical therapies to improve kidney and cardiovascular outcomes in patients with chronic kidney disease.
Pharmacists can play a crucial role in addressing care gaps and optimizing guideline-directed medical therapies for patients with chronic kidney disease.
DOI